Your Good Partner in Biology Research

  1. 首页
  2. 蛋白
  3. 重组蛋白
  4. Recombinant Mouse cAMP-dependent protein kinase type I-alpha regulatory subunit (Prkar1a)

Recombinant Mouse cAMP-dependent protein kinase type I-alpha regulatory subunit (Prkar1a)

  • 中文名称：
    小鼠Prkar1a重组蛋白
  • 货号：
    CSB-YP887580MO
  • 规格：
  • 来源：
    Yeast
  • 其他：
  • 中文名称：
    小鼠Prkar1a重组蛋白
  • 货号：
    CSB-EP887580MO
  • 规格：
  • 来源：
    E.coli
  • 其他：
  • 中文名称：
    小鼠Prkar1a重组蛋白
  • 货号：
    CSB-EP887580MO-B
  • 规格：
  • 来源：
    E.coli
  • 共轭：
    Avi-tag Biotinylated

    E. coli biotin ligase (BirA) is highly specific in covalently attaching biotin to the 15 amino acid AviTag peptide. This recombinant protein was biotinylated in vivo by AviTag-BirA technology, which method is BriA catalyzes amide linkage between the biotin and the specific lysine of the AviTag.

  • 其他：
  • 中文名称：
    小鼠Prkar1a重组蛋白
  • 货号：
    CSB-BP887580MO
  • 规格：
  • 来源：
    Baculovirus
  • 其他：
  • 中文名称：
    小鼠Prkar1a重组蛋白
  • 货号：
    CSB-MP887580MO
  • 规格：
  • 来源：
    Mammalian cell
  • 其他：

产品详情

  • 纯度：
    >85% (SDS-PAGE)
  • 基因名：
  • Uniprot No.：
  • 别名：
    Prkar1a; cAMP-dependent protein kinase type I-alpha regulatory subunit [Cleaved into: cAMP-dependent protein kinase type I-alpha regulatory subunit; N-terminally processed]
  • 种属：
    Mus musculus (Mouse)
  • 蛋白长度：
    full length protein
  • 表达区域：
    1-381
  • 氨基酸序列
    MASGSMATSE EERSLRECEL YVQKHNIQAL LKDSIVQLCT TRPERPMAFL REYFERLEKE EARQIQCLQK TGIRTDSRED EISPPPPNPV VKGRRRRGAI SAEVYTEEDA ASYVRKVIPK DYKTMAALAK AIEKNVLFSH LDDNERSDIF DAMFPVSFIA GETVIQQGDE GDNFYVIDQG EMDVYVNNEW ATSVGEGGSF GELALIYGTP RAATVKAKTN VKLWGIDRDS YRRILMGSTL RKRKMYEEFL SKVSILESLD KWERLTVADA LEPVQFEDGQ KIVVQGEPGD EFFIILEGTA AVLQRRSENE EFVEVGRLGP SDYFGEIALL MNRPRAATVV ARGPLKCVKL DRPRFERVLG PCSDILKRNI QQYNSFVSLS V
  • 蛋白标签：
    Tag type will be determined during the manufacturing process.
    The tag type will be determined during production process. If you have specified tag type, please tell us and we will develop the specified tag preferentially.
  • 产品提供形式：
    Lyophilized powder
    Note: We will preferentially ship the format that we have in stock, however, if you have any special requirement for the format, please remark your requirement when placing the order, we will prepare according to your demand.
  • 复溶：
    We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20℃/-80℃. Our default final concentration of glycerol is 50%. Customers could use it as reference.
  • 储存条件：
    Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.
  • 保质期：
    The shelf life is related to many factors, storage state, buffer ingredients, storage temperature and the stability of the protein itself.
    Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
  • 货期：
    Delivery time may differ from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
    Note: All of our proteins are default shipped with normal blue ice packs, if you request to ship with dry ice, please communicate with us in advance and extra fees will be charged.
  • 注意事项：
    Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
  • Datasheet ：
    Please contact us to get it.

产品评价

靶点详情

  • 功能：
    Regulatory subunit of the cAMP-dependent protein kinases involved in cAMP signaling in cells.
  • 基因功能参考文献：
    1. This mouse knockout model supports the role of prkar1a as a tumor suppressor gene in the pancreas and points to the PKA pathway as a possible therapeutic target for these lesions. PMID: 27803029
    2. This model, the first describing the germline expression of a PRKAR1A mutation causing dominant repression of cAMP-dependent PKA, reproduced the main features of acrodysostosis 1 in humans. PMID: 27589370
    3. These results therefore provide new information on the complex regulation of cellular death under endoplasmic reticulum stress conditions and bring new insights on the conditions that regulate the pro- versus anti-death functions of PKA. PMID: 27341185
    4. This study demonstrated that loss of one Prkar1a allele was associated with a significant increase in PKA activity in the basolateral (BLA) and central (CeA) amygdala and ventromedial hypothalamus (VMH) in both Prkar1a(+/-) and Prkar1a(+/-)/Prkaca(+/-) mice. PMID: 26992826
    5. Kidney-specific loss of Prkar1a induced renal cystic disease and markedly aggravated cystogenesis in the Pkd1(RC) models. PMID: 28615245
    6. data demonstrate that haploinsufficiency for either one of the type-II regulatory subunits improved the bone phenotype of mice haploinsufficient for Prkar1a PMID: 26246497
    7. PKARIalpha oxidation is an essential step in the angiogenic pathway. PMID: 26258640
    8. PRKAR1A gene and its locus are altered in mixed odontogenic tumors. Expression is decreased in a subset of tumors, and Prkar1a(+) (/) (-) mice do not show abnormalities, which indicates that additional genes play a role in this tumor's pathogenesis. PMID: 25870248
    9. Prkar1a activation enhances beta-catenin transcriptional activity through nuclear localization to PML bodies. PMID: 25299576
    10. Loss of Prkar1a can only promote tumorigenesis when Prkar1a-mediated apoptosis is somehow countered. PMID: 25012505
    11. Data show that mammary-specific loss of Prkar1a leads to elevated type-II PKA isozyme activation and this is sufficient to drive breast carcinogenesis. PMID: 24662820
    12. Results show that mouse Prkar1a and human PRKAR2A exhibited a dynamic spatio-temporal expression in tooth development, whereas neither human PRKAR1A nor mouse Prkar2a showed their expression in odontogenesis. PMID: 24755349
    13. Ablation of Prkar1a interferes with signaling pathways necessary for osteoblast differentiation. PMID: 24506536
    14. This study demonstrated a critical role for cytoplasmic RI-PKA holoenzyme in gene regulation and the overall physiological function of Striatal medium spiny neurons. PMID: 24695708
    15. hypoxia/reoxygenation (H/R)-mediated decrease in PKARIalpha protein levels leads to activation of RSK1, which via phosphorylation of NHE1 induces cardiomyocyte apoptosis. PMID: 24307699
    16. Prkar1a was found to play a critical role in peripheral nerve development. PMID: 24227708
    17. Dysregulated protein kinase A activity in the amygdala-prefrontal cortex circuitry in Prkar1a(+/-) mice is associated with behavioral phenotype of anxiety and a bias for threat PMID: 23531435
    18. PKA activation through mutation in Prkar1a is sufficient to initiate Rac1 signaling, with subsequent reduction of Nf2 and schwannomagenesis. PMID: 23045281
    19. Prkar1a is indeed a tumor suppressor in the thyroid and that loss of this gene leads to hyperthyroidism and follicular thyroid cancer PMID: 22514108
    20. Analysis of protein kinase A activity showed the loss of one Prkar1a allele led to an increase in basal and cAMP-stimulated kinase activity in both the basolateral and central amygdala PMID: 22024111
    21. PRKAR1A enables protein kinase A to phosphorylate BimEL PMID: 21151042
    22. Prkar1a is an osteosarcoma tumor suppressor that defines a molecular subclass in mice. PMID: 20697156
    23. Observations provide evidence of the essential role of proper regulation of PKA during the ossification of the bones of the skull PMID: 20534695
    24. a key role for AKAP-targeted PKA in control of heart rate and contractile function PMID: 20581396
    25. R1alpha loss results in improper maintenance and centrifugal expansion of cortisol-producing fetal adrenocortical cells with concomitant regression of adult cortex. PMID: 20548949
    26. Prkar1a haploinsufficiency leads to increase in tumors in the Trp53+/- or Rb1+/- backgrounds by dysregulation of the cell cycle and Wnt signaling. PMID: 20080939
    27. Allosteric communication between cAMP binding sites in the RI subunit of protein kinase A revealed by NMR. PMID: 20197278
    28. perilipin expression and phosphorylation state are critical regulators of lipid storage and hydrolysis in ACS1/FATP1 cells. PMID: 11751901
    29. AP7, which interacts with PBR and the PKA regulatory subunit RIalpha, is present in adrenal and gonadal cells and is found in mitochondria. Overexpression of full length PAP7 increased hormone-induced steroid production. PMID: 12530641
    30. Data show that neuregulin increases acetylcholine receptor delta subunit gene transcription, in part by the activation of protein kinase A/CREB, an alternative route to the previously reported ERK signaling pathway. PMID: 12727221
    31. protein kinase A RIalpha has a role in inhibiting carcinogen-induced mammary neoplasms PMID: 15240549
    32. concluded that although PRKAR1A haploinsufficiency does predispose to tumorigenesis, distinct secondary genetic events are required for tumor formation PMID: 15371594
    33. the tTA/X2AS mouse line with a downregulated Prkar1a gene replicates several of the findings in Carney complex patients and their affected tissues, supporting the role of RI as a candidate tumour suppressor gene PMID: 15591278
    34. RIalpha antisense produces anticarcinogenic effects by increasing DMBA detoxification in the liver and activating DNA repair processes in the mammary gland by downregulating PKA-1 [review] PMID: 16394142
    35. These results demonstrate that RIalpha is required for regulating PKA activity in maturing oocytes and that compensatory upregulation of RII does not occur. PMID: 16937372
    36. Phosphorylated-mTOR levels and mTOR activity were dramatically increased in prkar1a-/- cells. PMID: 16963469
    37. Prkar1a(+/-) mice develop bone tumors with high frequency and primary cultures of tumoral bone exhibited the expected decrease in Prkar1a protein. PMID: 17932105
    38. Data indicate that complete loss of Prkar1a is sufficient to allow the formation of pituitary tumors and abnormalities of the GH axis, in close analogy to human patients with CNC. PMID: 17975024
    39. Loss of Prkar1a from the heart causes myocardial development failure, cardiac failure & embryonic demise. These changes may be due to suppression of cardiac-specific transcription by increased protein kinase A activity, leading to myxoma-like changes. PMID: 18316483
    40. data indicate that PKA dysregulation triggered by loss of Prkar1a causes Schwann cell tumorigenesis through pathways that overlap, but are distinct from, those that cause NF1 and NF2 PMID: 18953430
    41. The protein kinase cAMP dependent regulatory type I alpha exhibited a uniform distribution throughout the sarcomer or weak and broad striations overlapping with F-actin signals. PMID: 19263518
    42. In mouse lung fibroblasts, silencing of the PKARIalpha increased the phosphorylation and activation of RSK1. PMID: 19570980

    显示更多

    收起更多

  • 亚细胞定位：
    Cell membrane.
  • 蛋白家族：
    CAMP-dependent kinase regulatory chain family
  • 数据库链接：

    KEGG: mmu:19084

    STRING: 10090.ENSMUSP00000056500

    UniGene: Mm.30039